These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 1578314

  • 21. Detection of prenatal drug exposure in the pregnant women and her newborn infant.
    Ostrea EM, Welch RA.
    Clin Perinatol; 1991 Sep; 18(3):629-45. PubMed ID: 1934859
    [Abstract] [Full Text] [Related]

  • 22. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse.
    Bar-Oz B, Klein J, Karaskov T, Koren G.
    Arch Dis Child Fetal Neonatal Ed; 2003 Mar; 88(2):F98-F100. PubMed ID: 12598495
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Testing for drugs of abuse in meconium of newborn infants.
    Moriya F, Chan KM, Noguchi TT, Wu PY.
    J Anal Toxicol; 1994 Mar; 18(1):41-5. PubMed ID: 8127083
    [Abstract] [Full Text] [Related]

  • 25. Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users.
    Oyler J, Darwin WD, Preston KL, Suess P, Cone EJ.
    J Anal Toxicol; 1996 Oct; 20(6):453-62. PubMed ID: 8889682
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Meconium for drug testing.
    Maynard EC, Amoruso LP, Oh W.
    Am J Dis Child; 1991 Jun; 145(6):650-2. PubMed ID: 1817465
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of cocaine use during pregnancy through toxicological analysis of hair.
    Chiarotti M, Strano-Rossi S, Offidani C, Fiori A.
    J Anal Toxicol; 1996 Jun; 20(7):555-8. PubMed ID: 8934305
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Head growth in cocaine-exposed infants: relationship to neonate hair level.
    Sallee FR, Katikaneni LP, McArthur PD, Ibrahim HM, Nesbitt L, Sethuraman G.
    J Dev Behav Pediatr; 1995 Apr; 16(2):77-81. PubMed ID: 7790518
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Neonatal hair analysis contribution to establishing a gestational drug exposure profile and predicting a withdrawal syndrome.
    Vinner E, Vignau J, Thibault D, Codaccioni X, Brassart C, Humbert L, Lhermitte M.
    Ther Drug Monit; 2003 Aug; 25(4):421-32. PubMed ID: 12883224
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Determination of gestational cocaine exposure by hair analysis.
    Graham K, Koren G, Klein J, Schneiderman J, Greenwald M.
    JAMA; 1989 Dec 15; 262(23):3328-30. PubMed ID: 2585678
    [Abstract] [Full Text] [Related]

  • 39. Gastric fluid analysis for determining gestational cocaine exposure.
    Garcia DC, Romero A, Garcia GC, Ostrea EM.
    Pediatrics; 1996 Aug 15; 98(2 Pt 1):291-3. PubMed ID: 8692634
    [No Abstract] [Full Text] [Related]

  • 40. Cocaine use during pregnancy assessed by hair analysis in a Canary Islands cohort.
    Joya X, Gomez-Culebras M, Callejón A, Friguls B, Puig C, Ortigosa S, Morini L, Garcia-Algar O, Vall O.
    BMC Pregnancy Childbirth; 2012 Jan 09; 12():2. PubMed ID: 22230295
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.